PURE Bioscience, Inc.

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP
74621T209
SEDOL
N/A
CIK
0001006028
www.purebio.com
LEI:
©
New: Infographics X-Lab
FIGI: BBG000BVNF18
PURE
PURE Bioscience, Inc.
GICS: - · Sector: Consumer Defensive · Sub-Sector: Household & Personal Products
AI
PROFILER
NAME
PURE Bioscience, Inc.
ISIN
US74621T2096
TICKER
PURE
MIC
XOTC
REUTERS
PURE.PK
BLOOMBERG
PURE US
F&G: 62
5.664,04 S&P · 21,93 Vola-Index · 103.440,30 BTC · 1,12506 EURUSD
BUILD THEMEFOLIO SHARE IDEAS DISCUSS
LEVERAGE INVEST
Financial Intelligence
360° iHub Crowd iFeed ATH Tracker Index Tracker ETF TF Spicy2 X-Billboard
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Mon, 17.03.2025       PURE Bioscience
US74621T2096

PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal second quarter ended January 31, 2025. Summary of Results – Fiscal Second Quarter Operations Net product sales were $391,000 and $325,000 for the fi...
Read More
PURE Bioscience
Technical Analysis Termsheet Terminal
Permalink
Tue, 21.01.2025       PURE Bioscience
US74621T2096

PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and Hydrite Chemical Company (“Hydrite”) have entered into a multi-year distribution agreement for the purchase and selling of SDC products under special terms and conditions. PURE is excited to an...
Read More
PURE Bioscience
Technical Analysis Termsheet Terminal
Permalink
Thu, 09.01.2025       PURE Bioscience
US74621T2096

PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and branded by Greenville (“bbG”), is excited to announce the official start of an extensive rebranding campaign to renew its corporate vision. This rebranding initiative aims to strengthen the Compa...
Read More
PURE Bioscience
Technical Analysis Termsheet Terminal
Permalink
Mon, 16.12.2024       PURE Bioscience
US74621T2096

PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2024. Summary of Results – Fiscal First Quarter Operations Net product sales were $555,000 and $718,000 for the fi...
Read More
PURE Bioscience
Technical Analysis Termsheet Terminal
Permalink
Wed, 20.11.2024       PURE Bioscience
US74621T2096

PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and AFCO, a Zep Company (“AFCO”), have entered into a multi-year distribution agreement for the purchase and selling of SDC products under special terms and conditions. PURE is excited to announce ...
Read More
PURE Bioscience
Technical Analysis Termsheet Terminal
Permalink
Fri, 01.11.2024       PURE Bioscience
US74621T2096

PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and Quip Laboratories, Inc. (“Quip Labs”), have entered into a multi-year distribution agreement for the purchase and selling of SDC products under special terms and conditions. PURE is pleased to a...
Read More
PURE Bioscience
Technical Analysis Termsheet Terminal
Permalink
Tue, 22.10.2024       PURE Bioscience
US74621T2096

PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and Madison Chemical Co., Inc. (“Madison Chemical”), have entered into a multi-year distribution agreement for the purchase and selling of SDC products under special terms and conditions. PURE is th...
Read More
PURE Bioscience
Technical Analysis Termsheet Terminal
Permalink
Wed, 09.10.2024       PURE Bioscience
US74621T2096

PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), has entered into a multi-year distribution agreement with Tennessee-based Zee Company to purchase and sell PURE’s patented antimicrobial products. This agreement will allow PURE, the non-toxic Silver Dihydrogen Citrate (SDC) antimicrobial creator, to purchase and sell its SDC pro...
Read More
PURE Bioscience
Technical Analysis Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S